TIDES Tracks - Event Guides

Oligonucleotide Discovery, Preclinical & Clinical Track

Explore the full journey from discovery to clinic in this forward-looking track designed to accelerate oligonucleotide therapeutics.

Gain insights

Design breakthrough drug-like properties that enhance stability, specificity, and efficacy
Fast-track candidate selection with smarter screening and predictive tools
Optimize clinical trial design to maximize success rates and minimize delays
Benchmark your strategies against the latest data and case studies from industry leaders

Featured Keynote Sessions

The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook

Dr. Lotte Bjerre Knudsen, PhD
Chief Scientific Advisor & Head of GLP-1 CoE at Novo Nordisk A/S

Tuesday, 20 May 2025
8:15am – 9:00am
Harbor Ballroom (Level 2)

Antibody Oligonucleotide Conjugates (AOCs): RNA Delivery Beyond the Liver

Mike Flanagan, PhD
Chief Scientific Officer at Avidity Biosciences

Tuesday, 20 May 2025
1:45pm – 2:30pm
Harbor Ballroom (Level 2)

Whether you’re advancing your first candidate or refining a robust pipeline, this track empowers you to innovate with confidence and speed. Make sure to check out our exciting sessions in these tracks.

#tidesusa